Study on Post-Surgery Antibiotic Use in Patients with Complicated Acute Appendicitis: Evaluating Metronidazole, Ceftriaxone, and Ofloxacin Hydrochloride

3 1 1 1

What is this study about?

This clinical trial is focused on studying the effects of post-operative antibiotic therapy in patients who have undergone a laparoscopic appendectomy for a condition known as complicated acute appendicitis. This condition involves inflammation of the appendix that may include complications such as a perforated appendix, which means the appendix has burst, or the presence of abscesses, which are collections of pus. The study aims to evaluate the impact of not using antibiotics after surgery on the rate of infections that occur in the area of the surgery.

The trial involves several medications, including metronidazole, glucose, ceftriaxone sodium, lidocaine hydrochloride, and ofloxacin hydrochloride. These medications are administered through infusion, which means they are given directly into the bloodstream. The study also includes a group that receives a placebo, which is a substance with no active medication, to compare the effects of the antibiotics.

Participants in the study will be monitored for a period of up to three days after their surgery. The main focus is to observe the occurrence of infections at the surgical site within 30 days after the operation. Additionally, the study will look at other factors such as the quality of life before and after surgery, the number of days without antibiotics, and the balance between antibiotic use and resistance to bacteria. The goal is to understand whether antibiotics are necessary after surgery for this type of appendicitis and to ensure the best outcomes for patients.

1 joining the study

Participation begins after a laparoscopic appendectomy for complicated acute appendicitis is performed. This condition is confirmed during surgery by the presence of a perforated appendix, extraluminal fecaliths, abscesses, or localized peritonitis.

Eligibility requires being 18 years or older and having signed an informed consent form.

2 randomization

Participants are randomly assigned to either receive post-operative antibiotic therapy or not. This is to evaluate the impact of not using antibiotics on the rate of infections at the surgical site.

3 treatment phase

If assigned to the antibiotic group, medications may include metronidazole, ceftriaxone, sodium chloride, and levofloxacin. These are administered through infusion.

The specific dosage, frequency, and duration of administration are determined by the study protocol and medical team.

4 monitoring and follow-up

Participants are monitored for signs of infection and other health indicators for 30 days after surgery.

The primary focus is on the occurrence of deep surgical site infections, which are infections that affect the area around the surgical site.

5 evaluation of outcomes

The study evaluates the quality of life before surgery and upon discharge using specific questionnaires.

Other outcomes include the rate of superficial infections, the number of days without antibiotics, and the balance between antibiotic use and microbial resistance.

6 completion of study participation

Participation concludes after the 30-day post-operative period, with a final assessment of health outcomes and any potential rehospitalization.

Who Can Join the Study?

  • The patient must have complicated acute appendicitis confirmed during surgery. This means the appendix is perforated, there are fecaliths (small stones made of feces) outside the appendix, abscesses (pockets of pus), or localized peritonitis (infection in one or two areas of the abdomen).
  • The patient must have had a laparoscopic appendectomy, which is a surgery to remove the appendix using small cuts and a camera.
  • The patient must be 18 years or older.
  • The patient must have signed an Informed Consent Form (ICF), which means they agree to participate in the study after understanding what it involves.

Who Cannot Join the Study?

  • Patients with generalized peritonitis cannot participate. This is a condition where there is widespread inflammation in the lining of the abdomen.
  • Patients who are not within the specified age range cannot participate. The study is open to certain age groups only.
  • Patients who are part of a vulnerable population cannot participate. This means people who might need special protection or care.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

Site Name City Country Status
University Hospital Of Clermont-Ferrand Clermont Ferrand France
Centre Hospitalier Universitaire De Lille Lille France
CHU Grenoble Alpes La Tronche France

Other Sites

Site Name City Country Status
Centre Hospitalier Universitaire Rouen Rouen France
Centre Hospitalier De Tourcoing Tourcoing France
Centre Hospitalier Universitaire De Montpellier Montpellier France
Centre Hospitalier De Saint-Quentin Saint Quentin France
Centre Hospitalier Universitaire Amiens Picardie Amiens France
Centre Hospitalier Simone Veil De Beauvais Beauvais France
Centre Hospitalier Lyon Sud Pierre Benite France
Hopital Beaujon Clichy France
Centre Hospitalier Universitaire De Caen Normandie Caen France
Centre Hospitalier De Pau Pau France
Hfhyupwo Uxyscidknqlbha dk Mlqoibqex Tkknjt Marseille France
Gfgnhh Hhgevcvgrgo Njsb Euubxez Orsay France
Ctwhit Hdscrpefnyu Eq Uhtosmkjjooao Dr Lziwugd Limoges France
Cjjoqw Hcvathvlvlf Ubveyxbrgqozq Df Drtgx Dijon France
Cxizvl Hlrersbkqvc Rmztymrm Dizdbtzbgangev Angers France

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
France France
Not yet recruiting
22.10.2018

Trial locations

Antibiotic Therapy is used in this clinical trial to treat patients after they have undergone a laparoscopic appendectomy for complicated acute appendicitis. The study is evaluating the impact of not using antibiotics after surgery to see if it affects the rate of infections at the surgical site.

Investigated diseases:

Complicated Acute Appendicitis – This condition occurs when the appendix, a small pouch attached to the large intestine, becomes inflamed and infected, leading to a more severe form of appendicitis. It is characterized by the presence of complications such as perforation, abscess, or peritonitis, which is an inflammation of the lining of the abdominal cavity. The disease typically begins with abdominal pain, often starting around the navel and then shifting to the lower right side. As the condition progresses, symptoms may include fever, nausea, vomiting, and an increase in pain intensity. If not treated promptly, the appendix can rupture, leading to widespread infection in the abdomen.

Trial ID:
2024-515834-34-00
Protocol code:
PI2017_843_0002
NCT ID:
NCT03688295
Trial Phase:
Therapeutic confirmatory (Phase III)

Other Trials to Consider

  • Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands
  • Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

    Recruiting

    3 1 1
    Investigated drugs:
    Czechia Lithuania Slovakia Slovenia